$PDSB.US is showing a sharp momentum move. The stock closed around $0.59 on Sept. 15, up about 46.7%, after trading as high as $0.76 with very heavy volume.
🔹 Catalyst: PDS Biotech recently announced an initial $11.3M PIPE financing, with total financing potentially reaching about $22.3M, alongside the appointment of Dr. Patrick Soon-Shiong to its board.
🔹 Momentum: The stock has gained roughly 210% over five trading days according to recent market data.
🔹 Risk: The move is highly volatile, and the financing includes new shares/warrants, creating potential dilution.
Key levels: Watch $0.60–$0.65 for continuation and $0.40–$0.45 as an important pullback zone.
#PDSB #FedRateWatch #ZcashRises6% #BitcoinFalls4% #ZcashHoldersBackNU7Upgrade
🔹 Catalyst: PDS Biotech recently announced an initial $11.3M PIPE financing, with total financing potentially reaching about $22.3M, alongside the appointment of Dr. Patrick Soon-Shiong to its board.
🔹 Momentum: The stock has gained roughly 210% over five trading days according to recent market data.
🔹 Risk: The move is highly volatile, and the financing includes new shares/warrants, creating potential dilution.
Key levels: Watch $0.60–$0.65 for continuation and $0.40–$0.45 as an important pullback zone.
#PDSB #FedRateWatch #ZcashRises6% #BitcoinFalls4% #ZcashHoldersBackNU7Upgrade
